A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 162 participants.
Also called NCT01052779
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 162 participants
- Sponsor
- Registry
-
NCT01052779 -
2009-015630-30
-
- Other papers using this trial's data
- A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Belgium, Canada, Germany, India, Poland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01052779. Randomized; no masking; primary purpose treatment. Start 2010-03-01 (actual); primary completion 2011-07-19 (actual). Results posted on 2018-05-15.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease
- Acronym
- FIRST
- Condition
- Iron Deficiency
- Condition
- Anemia
- Condition
- Kidney Disease
- Intervention (Drug)
- Ferumoxytol
- Intervention (Drug)
- Iron Sucrose
- Lead sponsor
- AMAG Pharmaceuticals, Inc.
Record details
- Record id
cardio:ct-nct01052779- Content hash
f7b0bd0d71650b1b13e600388fae45ea8e9d8d7feffc4176419773fabf2337bd